Tesamorelin + Ipamorelin Blend Research Measurement Tools

The measurement tools that matter for a tesamorelin + ipamorelin blend are analytical instruments and documented test panels, not anything that sits on your own bench. Reverse-phase HPLC establishes purity and separates the two sequences; mass spectrometry confirms identity; Karl Fischer titration or loss-on-drying quantifies residual water; and microbial and endotoxin assays cover contamination. For a wholesale buyer, the practical question is narrower than the instrument list: which of these tests does the supplier run on every batch, and can you retrieve the certificate of analysis yourself without asking someone's permission?

That last point is where most sourcing decisions are actually won or lost. Every supplier in this category will tell you their material is tested. Far fewer will hand you a per-batch document, with a lot number that matches the vial, that you can read before you place an order. All compounds discussed here are research use only and are not for human consumption.

What each analytical method actually answers

Analytical chemistry for peptides is not one test. It is a panel, and each line answers a different failure mode. Understanding what each method covers tells you immediately whether a supplier's documentation is complete or decorative.

A supplier running a seven-panel battery across batches is covering these categories rather than reporting a single purity figure and calling it documentation. When you compare programs, compare panels — not adjectives.

Why two peptides in one vial complicate the chemistry

Tesamorelin is a 44-residue growth hormone releasing factor analog. Ipamorelin is a pentapeptide. Those are very different molecules by size, hydrophobicity and behavior in solution, and that difference cuts both ways for measurement.

On the helpful side, the size gap usually means the two compounds elute at clearly different retention times on a reverse-phase gradient, so separation is chromatographically achievable. On the difficult side, a single HPLC method tuned for a small pentapeptide is rarely the same method that resolves a 44-residue chain and its close-eluting deletion sequences. Running one generic gradient over a blend can produce a clean-looking trace that quietly buries impurities under a broad peak.

Ratio verification is the second complication. A blend implies a stated proportion between the two compounds. Confirming that proportion requires quantitative work against reference standards for each peptide individually — not a single area-percent purity figure. Many blend COAs in circulation report one purity number for the vial and never document the ratio at all, which means the buyer is trusting a fill process they cannot inspect.

Stability is the third. Research on peptide degradation consistently indicates that stability is sequence-specific — oxidation, deamidation and aggregation pathways differ between molecules. Two compounds sharing a vial share storage conditions whether or not those conditions suit both. This is one reason many buyers building a catalog prefer single-compound vials: they are simpler to verify, simpler to document, and simpler to trace when a customer asks a question.

Reading a certificate of analysis instead of trusting one

A COA is only useful if it is specific enough to be falsifiable. Work through this list the first time you evaluate any supplier:

• Lot number on the document matches the lot printed on the vial. A COA tied to a product rather than a batch is a brochure.
• Test date and method are stated. Column, gradient, detection wavelength, instrument — the level of detail a chemist would need to reproduce the run.
• The chromatogram is attached, not summarized. A purity percentage with no trace behind it cannot be checked by anyone.
• Mass confirmation appears alongside purity. Identity and purity are separate claims.
• The panel is disclosed in full, including which tests were run in house and which were sent to a third-party lab.
• For a blend, the ratio is documented with the method used to determine it.

The corresponding red flags are just as clear: undated documents, generic per-product COAs reused across batches, purity claims with no supporting data, laboratory names that cannot be located, and — a practice worth walking away from — COAs offered only after purchase or as a paid add-on. Test documentation that costs extra is not test documentation; it is a revenue line.

Questions to put to a supplier before your first wholesale order

Measurement quality is one dimension of a sourcing decision. These are the others worth resolving in writing before you commit inventory budget:

Is pricing visible without a sales call? Programs that hide tier structure behind a negotiation tend to price inconsistently. You want to know how tiers are built and what moves you between them. Actual margins in this category vary widely by volume, category and how you position your catalog, and any supplier quoting you a guaranteed margin figure is telling you something they cannot know.

Are COAs public and per batch? If you cannot look up a lot number before buying, you are relying on a promise.

Where does fulfillment originate, and what is the realistic lead time? Domestic fulfillment materially changes how you plan reorders compared with international shipping and customs exposure.

How consistent is batch-to-batch supply? Ask what happens when a lot fails an internal specification. The answer tells you whether quality control has teeth.

How is the material labeled? Research-use-only labeling should be unambiguous on the vial and the documentation. Anything that blurs that line creates a problem you inherit.

What is the application process? A serious wholesale program qualifies its buyers. A program that ships bulk to anyone with a credit card is not managing risk on either side.

Storage and handling variables that change what you measure

An analytical result describes material at the moment of testing. What arrives at your door has since traveled. Lyophilized peptides are generally more stable than material in solution, but temperature excursions during transit, repeated freeze-thaw cycles, light exposure and humidity all matter, and their impact is sequence-dependent rather than uniform.

Practically, that means your receiving process is part of your quality system. Record lot numbers against your own inventory. Keep the COA for every lot you accept. Note packaging condition on arrival. If you are reselling, this record is the difference between answering a downstream question in minutes and having no answer at all.

If any part of your program involves animal models, handling, housing and welfare questions belong with a licensed veterinarian and your institution's review process — talk to your veterinarian about those, not your supplier.

Where the compliance line sits for a business buyer

This section is informational and is not legal advice. Research-use-only material sits in a regulatory space that varies by jurisdiction and by business model, and the honest guidance is to identify the questions rather than assume the answers.

The questions worth putting to your own attorney and, where relevant, your state board include: how research-use-only material is classified for your specific entity type; what labeling and record-keeping obligations attach to resale in your jurisdiction; whether your business license, professional license or facility registration covers the activity you are planning; and how your marketing language could be read by a regulator. Generally, the framework differs meaningfully between a reseller, a research organization and a licensed facility, and what applies to one does not transfer to another.

No supplier — including Real Peptides — can resolve those questions for you, and any supplier that offers to should raise your eyebrows. Get counsel who knows your state and your model.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built around documentation the buyer can check independently. Material is tested to 99%+ HPLC purity, and every batch runs through a seven-panel testing battery covering the categories described above rather than a single purity figure. Certificates of analysis are publicly verifiable — the reader can look up lab results directly rather than requesting them from a sales representative or paying for them as an extra.

Fulfillment is handled domestically, with orders shipping in five to seven days, which makes reorder planning a calculation rather than a guess. Onboarding runs through a three-step wholesale application designed to qualify business buyers rather than process anonymous bulk orders.

On the specific question of blends: the catalog lists Tesamorelin and Ipamorelin as separate single-compound vials. For buyers who care about verifiable measurement, that is a feature rather than a limitation — single-compound material is cleaner to analyze, cleaner to document per batch, and cleaner to trace when someone downstream asks what is in a vial. Everything in the catalog is supplied for laboratory and research use only and is not for human consumption.

If you are building or expanding a catalog and the documentation standard above matches how you want to source, the next step is the Wholesale Partner Program application. It takes three steps, it qualifies your business, and it gives you access to tier pricing and the same batch records your customers may eventually ask you about.

For readers evaluating specific compounds, the individual product pages for Tesamorelin 10mg and Ipamorelin 10mg carry batch documentation, as does the related secretagogue research compound CJC-1295 No DAC 10mg; buyers assembling a broader catalog often review the Growth Factor & Tissue Signaling Research collection and the Popular Peptides range alongside recovery-focused compounds such as BPC-157 10mg.